Tectonic Therapeutic (TECX) Accumulated Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Accumulated Expenses data on file, last reported at $9.0 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $9.0 million, up 82.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (up 82.86% YoY), and the FY2025 annual result was $7.3 million, down 6.5% from the prior year.
• Accumulated Expenses climbed to $9.0 million in Q1 2026 per TECX's latest filing, from $7.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $20.0 million in Q2 2024 and troughed at $1.1 million in Q1 2024.
• A 5-year average of $8.6 million and a median of $7.8 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses plunged 82.34% in 2023, then soared 441.81% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $11.7 million in 2022, then slumped by 30.61% to $8.1 million in 2023, then declined by 3.57% to $7.8 million in 2024, then declined by 6.5% to $7.3 million in 2025, then grew by 22.25% to $9.0 million in 2026.
• Business Quant data shows TECX's Accumulated Expenses at $9.0 million in Q1 2026, $7.3 million in Q4 2025, and $6.8 million in Q3 2025.